- SEK72.91bn
- SEK81.05bn
- SEK34.97bn
Getinge limits sale of heart devices in the US after FDA warning
Brief: Getinge Says Financial Target 2024-2028 Is Adjusted EPS Growth Of Above 12% On Average
Medical gear maker Getinge falls after FDA issues safety warning
Medical gear maker Getinge plummets after FDA issues safety warning
US FDA advises healthcare facilities to switch from Getinge's heart devices (updated)
US FDA recommends healthcare providers switch from Getinge's heart devices
Europe Research Roundup: Adriatic Metals, Diageo, GB Group
Brief: Getinge Sees FY 2024 Quality-Related Costs At About Half Of Costs In 2023
Medical gear maker Getinge's Q1 core profit beats expectations (updated)
Brief: Getinge Keeps 2024 Net Sales Outlook Unchanged
Medical gear maker Getinge's Q1 core profit beats expectations
Brief: Getinge Q1 Adjusted EBITA SEK 842 Million Vs. IBES Estimate SEK 809.5 Million
Earnings Poll: Getinge AB first quarter results due on April 22
Brief: Getinge Gets EU MDR Approval Of Advanta V12 Covered Stent System
Brief: Getinge - Launch Of Vasoview Hemopro 3 To Occur In US During Q3 2024
Brief: - FDA Grants Clearance For Getinge's Vasoview Hemopro 3
Brief: Tüv Süd Temporarily Suspends Getinge's CE Certificate For Cardiosave
Europe Research Roundup: Adidas, Fevertree Drinks, Volvo Car
Getinge shares plummet on Q4 profit miss